Roivant Sciences: Funding, Investors & Team (Oct 2026)
With the speedy delivery of cutting-edge treatments and technologies to patients, Roivant seeks to improve health. We accomplish this by establishing Vants, nimble, entrepreneurial biotech and healthcare technology businesses with a distinctive method for finding talent, coordinating incentives, and implementing technology. Many rare and fatal paediatric disorders, uterine fibroids, endometriosis, prostate cancer, Parkinson's disease, diabetes, and pulmonary arterial hypertension are among the ailments that are being treated by the medicines that are being developed by our family of firms. We concentrate on disease areas where company R&D spending is disproportionately little compared to societal medical demands. We also create technology-focused Vants aimed at enhancing the process of developing and marketing medications in addition to our biopharmaceutical companies.
Roivant Sciences has raised $400M across 2 funding rounds on record, the most recent an undisclosed round of $200M announced in Feb 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Roivant Sciences Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Roivant Sciences Funding Rounds
Roivant Sciences raised $200M in a Post-IPO Equity announced in Oct 2021.
1.3 years later, an undisclosed round of $200M was announced in Feb 2023.
Roivant Sciences Founders and Leadership Team
Contact details for the Roivant Sciences team: 1 of 2 have an email address on file.
Start 14-day free trial →Roivant Sciences Funding Compared to Other Biotechnology Startups
Roivant Sciences' latest round of $200M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Roivant Sciences in Biotechnology and New York
Companies Similar to Roivant Sciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Roivant Sciences Funding FAQs
What does Roivant Sciences do?
With the speedy delivery of cutting-edge treatments and technologies to patients, Roivant seeks to improve health. We accomplish this by establishing Vants, nimble, entrepreneurial biotech and healthcare technology businesses with a distinctive method for finding talent, coordinating incentives, and implementing technology. Many rare and fatal paediatric disorders, uterine fibroids, endometriosis, prostate cancer, Parkinson's disease, diabetes, and pulmonary arterial hypertension are among the ailments that are being treated by the medicines that are being developed by our family of firms. We concentrate on disease areas where company R&D spending is disproportionately little compared to societal medical demands. We also create technology-focused Vants aimed at enhancing the process of developing and marketing medications in addition to our biopharmaceutical companies.
How much funding has Roivant Sciences raised?
Roivant Sciences has raised $400M across 2 rounds on record. The most recent is an undisclosed round of $200M announced in Feb 2023.
When did Roivant Sciences last raise funding?
Roivant Sciences' most recent funding round on record is an undisclosed round of $200M, announced in Feb 2023.
Who founded Roivant Sciences?
FundedIQ lists Vivek Ramaswamy (Founder) at Roivant Sciences.
Who is the CEO of Roivant Sciences?
Regina Sav is listed as CEO at Roivant Sciences.
Where is Roivant Sciences headquartered?
Roivant Sciences is based in New York, United States.
How many employees does Roivant Sciences have?
Roivant Sciences is in the 501-1000 employee band.
How does Roivant Sciences' funding compare to other Biotechnology startups?
Roivant Sciences' latest round of $200M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Roivant Sciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Roivant Sciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.